Cours Acerus Pharmaceuticals Corporation Toronto S.E.
Actions
ASP
CA00444G4051
Produits pharmaceutiques
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01/05/18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17/07/20 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09/09/13 |
Borys Chabursky
BRD | Director/Board Member | - | 20/12/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,68 % | 681 Md | |
+19,65 % | 556 Md | |
-4,35 % | 361 Md | |
+17,65 % | 325 Md | |
+3,77 % | 285 Md | |
+14,24 % | 235 Md | |
+4,37 % | 199 Md | |
-11,94 % | 189 Md | |
-3,79 % | 157 Md |